Related Experiment Video

Updated: Mar 15, 2026

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.6K

Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery

Yimu Zhao1, Anastasia Korolj1,2, Nicole Feric2,3

  • 1a Department of Chemical Engineering and Applied Chemistry , University of Toronto , Toronto , Ontario , Canada.

Expert Opinion on Drug Safety
|August 26, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Cardiomyocytecardiotoxicitydrug discoveryengineered cardiac tissuehigh throughput screeninghuman pluripotent stem cells

More Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.5K
Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

11.0K

Related Experiment Videos

Last Updated: Mar 15, 2026

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.6K
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.5K
Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

11.0K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K

Articles linked to this work by shared authors, journal, and citation graph.

In vitro multi-organ invasion model for exploring cardiac resistance to cancer metastasis.

Nature communications·2026

Engineering adaptive self-healing biomaterials from jammed microfluidic elastomeric particles.

Materials today. Bio·2026

Epicardial extracellular vesicles modulate gene expression following ischemia-reperfusion injury in heart-on-a-chip.

Materials today. Bio·2026

Guiding the spatial organization of engineered heart tissues.

Advanced drug delivery reviews·2026

Mapping the miRNA landscape of primitive macrophage extracellular vesicles highlights their pro-vasculogenic effects in engineered human cardiac tissue.

APL bioengineering·2026

Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media components.

Nature communications·2026

Safety of treatments for children with functional constipation.

Expert opinion on drug safety·2026

Early recognition, prevention, and management of glucocorticoid toxicity in patients with rheumatic diseases.

Expert opinion on drug safety·2026

Lesser-known medication safety considerations in sickle cell disease.

Expert opinion on drug safety·2026

Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.

Expert opinion on drug safety·2026

Long-term efficacy and safety of intra-articular corticosteroid injections in patients with knee osteoarthritis.

Expert opinion on drug safety·2026

Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies.

Expert opinion on drug safety·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us